Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) Operating Expenses: 2014-2025

Historic Operating Expenses for Ocugen (OCGN) over the last 11 years, with Sep 2025 value amounting to $19.4 million.

  • Ocugen's Operating Expenses rose 34.67% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.1 million, marking a year-over-year increase of 13.98%. This contributed to the annual value of $58.8 million for FY2024, which is 17.82% down from last year.
  • As of Q3 2025, Ocugen's Operating Expenses stood at $19.4 million, which was up 27.75% from $15.2 million recorded in Q2 2025.
  • Ocugen's 5-year Operating Expenses high stood at $25.6 million for Q2 2021, and its period low was $7.1 million during Q1 2021.
  • In the last 3 years, Ocugen's Operating Expenses had a median value of $16.0 million in 2025 and averaged $16.4 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 651.25% in 2021, then crashed by 46.63% in 2023.
  • Ocugen's Operating Expenses (Quarterly) stood at $14.6 million in 2021, then spiked by 66.31% to $24.2 million in 2022, then crashed by 46.63% to $12.9 million in 2023, then rose by 12.91% to $14.6 million in 2024, then soared by 34.67% to $19.4 million in 2025.
  • Its last three reported values are $19.4 million in Q3 2025, $15.2 million for Q2 2025, and $16.0 million during Q1 2025.